Trials / Completed
CompletedNCT01667250
Non-Invasive Neurostimulation for the Prevention of Chronic Migraine
Non-Invasive Neurostimulation of the Vagus Nerve With the GammaCore Device for the Prevention of Chronic Migraine
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- ElectroCore INC · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this multi-center, prospective, double-blind, randomized, sham-controlled pilot study is to study feasibility and collect preliminary clinical data related to the safety and clinical benefits of daily use of non-invasive vagal nerve stimulation with the GammaCore device for the prevention of chronic migraine, and to support the development and approval of a larger pivotal study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GammaCore Active Device | |
| DEVICE | GammaCore Sham Device |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-08-17
- Last updated
- 2018-06-20
- Results posted
- 2018-06-20
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01667250. Inclusion in this directory is not an endorsement.